BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2014
View Archived Issues
Novel biomarkers of cardiovascular injury and disease presented at the ACC meeting
Read More
New NHE-1 inhibitor to prevent cardiovascular disease-related reperfusion injury
Read More
Hepatera begins pilot study of Myrcludex B in HDV
Read More
Defense Department grant funds gene therapy study for ALS
Read More
U.S. proof-of-concept study of Glassia begins in GVHD
Read More
Astellas submits MAA for Xtandi for chemotherapy-naive mCRPC
Read More
Adempas approved in the E.U. for two life-threatening forms of pulmonary hypertension
Read More
Regado Biosciences extends enrollment in phase III trial of REG-1
Read More
Allegro Diagnostics reports results from BronchoGen genomic test trial
Read More
MDxHealth and LI PATH enter into marketing agreement for ConfirmMDx
Read More
First patient enrolled in phase III trial of clonidine gel for diabetic neuropathy
Read More
Rosetta Genomics and Marina Biotech to develop microRNA products for rare diseases
Read More
Cepheid confirms launch of Xpert HPV, a rapid test for cervical cancer-related HPV
Read More
NICE recommends the exhaled nitric oxide testing to diagnose and manage asthma
Read More
Reata Pharmaceuticals reports discovery of NO production inhibitors
Read More
Qbtech launches FDA-cleared ADHD test
Read More
Mitsubishi Tanabe Pharma and Shanghai Pharmaceuticals jointly present novel renin inhibitors
Read More
Australian researchers report development of ICMT inhibitors
Read More
Eternity Bioscience prepares new B-raf inhibitors
Read More
Study of RO-5186582 enrolling subjects with Down syndrome
Read More
Gilead Sciences reports data from phase III study of sofosbuvir in HCV in Japan
Read More
Researchers identify potential biomarker of mitochondrial dysfunction in acute kidney injury
Read More
FDA clears IND for OMS-721 in thrombotic microangiopathies
Read More
Janssen begins phase III OPTIMIST trials of simeprevir in combination with sofosbuvir
Read More
Cytonet's liver cell therapy shows benefit in patients
Read More